by MV Blagosklonny - 2004 - Cited by 12 - Related articles

by P Loadman - 2002

by CM Walko - Cited by 12 - Related articles

Apr 11, 2011 – Dainippon Sumitomo Pharma (DSP) and Boston Biomedical (BBI) have signed a product option license agreement for BBI608 for all oncology .

by D Schipper - 1997 - Cited by 14 - Related articles

File Format: PDF/Adobe Acrobat - Quick View

The DME MAC Jurisdiction A Medical Review section contains the content previously hosted at Tricenturion Inc.

We illustrate the important aspects of a mass balance study with literature on anticancer drugs. This review could serve as guidance for future mass balance .

by S Crunkhorn - 2010

by M HIROTA - 2004

by AL Mayburd - 2008 - Cited by 6 - Related articles

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.

Anticancer Drugs Jan 2008. Where are we now? History of cancer treatment . A review by the Cellular, Tissue and Gene Therapies Advisory Panel found that .

by W Ying - 2008 - Cited by 7 - Related articles

Nov 23, 2010 – This post has been viewed 3389 times. Related posts:Halaven: 5 Warnings and precautions 5.1 Neutropenia Severe neutropenia (ANC < 500/mm3) .

Review Pharmacological factors influencing anticancer drug selection in the elderly. . Review Pharmacology of anticancer drugs in the elderly population. .

by AR Hanauske - 1995 - Related articles

Book Reviews. Anticancer Drug Development Guide. Preclinical Screening,. Clinical Trials, and Approval, Second Edition. Beverly A. . 阅读完整评论内容 .

by SA Roberts - 2011

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.

Overview; Reader Reviews; Critic Reviews (1) . Book Reviews. from springerlink .com. Book Reviews. Anticancer Drug Development Guide. Preclinical Screening .

by E Espinosa - 2003 - Cited by 25 - Related articles

Jun 22, 2011 – Frontiers in Pharmacology of Anti-Cancer Drugs welcomes the following tier 1 article types: Book Review, Clinical Case Study, Clinical Trial .

Reviews - The availability of new molecular approaches to the selection of drug therapy . in Anticancer Drug Development and Clinical Response (Reviews) .

Thank you for choosing to subscribe to the eTOC for Anti-Cancer Drugs. Enter your Email address: . Editorial; Review Articles. Select All .

May 27, 2011 – One Response to “Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug Reviews”. "nialw" says: May 27, 2011 at 9:56 am .

by MJ Deenen - 2011

by G Fritz - 2005 - Cited by 38 - Related articles

This review introduces concepts relevant to the use of viruses as anticancer drugs, emphasizing targeting mechanisms as well as safety and efficacy issues .

by H Gurney - 1996 - Cited by 228 - Related articles

Jul 8, 2007 – Following a review of cancer causes and progression, current treatments, . Ideal for those involved in anticancer drug research, .

by EA Sausville - 2006 - Cited by 89 - Related articles

Jul 3, 2011 – Doxorubicin is one of the most effective anticancer drugs. It is prescribed to treat a wide variety of cancers, usually in conjunction with .

by JH Atkins - 2002 - Cited by 43 - Related articles

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.

Global Cancer Market Review 2008 (World Top Ten Cancer Drugs):World Best Selling Top Ten Anticancer Drugs, Leading Companies, Market Trends [Internet]. .

by JY Zhang - 2002 - Cited by 19 - Related articles

by S Sengupta - 2006 - Cited by 13 - Related articles

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.

Nov 23, 2010 – Drug Name: HALAVEN (Brand Name Drug) Active Ingredient: ERIBULIN MESYLATE Company: Eisai Inc Original Approval Date FDA: November 15, 2010 .

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.

File Format: PDF/Adobe Acrobat - Quick View

Jun 10, 2011 – Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of .

Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles, and guest edited thematic issues on recent patents in the field of .

File Format: PDF/Adobe Acrobat - Quick View

by MA Jordan - 2004 - Cited by 858 - Related articles

by S Geiger - 2010 - Cited by 5 - Related articles

by S MALIK - 2011 - Cited by 2 - Related articles

The anticancer drugs embody a diverse array of chemical structures. The purpose of this two volume publication is to provide a comprehensive review of the .

Integrating genetic approaches into the discovery of anticancer drugs. Science. 1997 Nov 7;278(5340):1064-8. Review. PubMed PMID: 9353181. .

Sitemap